IP Library Granted Patent US 10,124,063
Granted Patent B2
US 10,124,063 · App. 14/833,597 · Granted Nov 13, 2018

Stable compositions containing thrombin and methods for preparation and use thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,124,063
App. No.
14/833,597
Granted
Nov 13, 2018
Kind
B2
Abstract

Compositions comprising thrombin and collagen and methods of preparation thereof are disclosed herein. In one embodiment, a composition comprises thrombin and collagen in an aqueous buffer solution, wherein the buffer solution includes at least one of a first compound represented by Formula I: R 1 —C(O)—O − M + , wherein R 1 is —CH 3 , —CH 2 CH 2 C(O)OH, or —CH 2 CH 2 C(O)O − M + , and wherein M + is a monovalent ion; or a second compound represented by Formula II: R 2 —C(O)—O − M 2+− O—C(O)—R 2 , wherein R 2 is —CH 3 or —CH 2 CH 3 , and wherein M 2+ is a divalent ion. In one embodiment, the buffer solution includes sodium acetate, calcium propionate, and sorbitol.

Claims (30)

1. An aqueous buffer solution, comprising:

sorbitol;

a first compound; and

a second compound,

wherein the first compound is represented by the following Formula I:

wherein R 1 is —CH 3 and wherein M + is a sodium ion (Na + );

wherein the second compound is represented by the following Formula II:

wherein R 2 is CH 2 CH 3 and wherein M 2+ is a calcium ion (Ca 2+ ), and

wherein the buffer solution does not include a chloride-containing salt.

2. The buffer solution of claim 1 , wherein the pH of the composition ranges from about 5.0 to about 8.5.

3. An aqueous buffer solution, comprising:

sodium succinate,

calcium propionate, and

sorbitol

wherein the buffer solution does not include a chloride-containing salt.

4. The buffer solution of claim 3 , wherein the sodium succinate is dibasic.

5. The buffer solution of claim 1 , wherein an amount of the first compound ranges from about 1 mg/ml to about 50 mg/ml.

6. The buffer solution of claim 1 , wherein an amount of the second compound ranges from about 1 mg/ml to about 50 mg/ml.

7. The buffer solution of claim 1 , wherein an amount of the sorbitol ranges from about 2.5 wt % to about 20 wt % of the buffer solution.

8. A composition including pepsinized microfibrillar collagen and thrombin in the aqueous buffer solution of claim 1 , wherein an initial thrombin activity ranges from about 400 to about 500 units of enzyme activity per milliliter of buffer solution.

9. The composition of claim 8 , where the thrombin is bovine thrombin or recombinant thrombin.

10. The composition of claim 8 , wherein an amount of the sorbitol ranges from about 0.1 to about 10 wt % of the composition.

11. The composition of claim 8 , wherein an amount of the first compound ranges from about 0.1 wt % to about 5 wt % of the composition, and wherein an amount of the second compound ranges from about 0.1 wt % to about 5 wt % of the composition.

12. The buffer solution of claim 3 , wherein an amount of the sodium succinate ranges from about 1 mg/ml to about 50 mg/ml.

13. The buffer solution of claim 3 , wherein an amount of the calcium propionate ranges from about 1 mg/ml to about 50 mg/ml.

14. The buffer solution of claim 3 , wherein an amount of the sorbitol ranges from about 2.5 wt % to about 20 wt % of the buffer solution.

15. A composition including pepsinized microfibrillar collagen and thrombin in the aqueous buffer solution of claim 3 , wherein an initial thrombin activity ranges from about 400 to about 500 units of enzyme activity per milliliter of buffer solution.

16. The composition of claim 15 , where the thrombin is bovine thrombin or recombinant thrombin.

17. The composition of claim 15 , wherein an amount of the sorbitol ranges from about 0.1 to about 10 wt % of the composition.

18. The composition of claim 15 , wherein an amount of the sodium succinate ranges from about 0.1 wt % to about 5 wt % of the composition, and wherein an amount of the calcium propionate ranges from about 0.1 wt % to about 5 wt % of the composition.

Assignments (3)
CHANGE OF ADDRESS Recorded Dec 18, 2024
From: STRYKER CORPORATION
To: STRYKER CORPORATION
Reel/Frame 069737/0184 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 1, 2023
From: ORTHOVITA, INC.
To: STRYKER CORPORATION
Reel/Frame 065735/0360 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2015
From: GARIGAPATI, VENKAT R.
To: ORTHOVITA, INC.
Reel/Frame 036428/0430 →